Clients around the world appreciate Leanne’s uniquely creative skills in identifying patentable technologies and drafting “outside the box” patent applications, particularly at a time when courts are limiting patent eligibility. Her practice also includes IP portfolio strategy and management, client counseling, freedom-to-practice opinions and due-diligence assessments. Leanne also provides FDA regulatory counsel including patent-drug FDA advice, Patent Term Extension applications and Orange Book assessments.
Leanne’s technical prowess is a rare blend that ranges from chemistry to biotechnology. As a leader in the firm’s Chemical and BioPharma practice groups, her client portfolio includes large and small pharmaceutical, life science, chemical, biotechnology, biofuels, cosmetics, and food processing companies. More specifically, clients come to Leanne to protect a wide-range of innovations, including small molecule chemistry, biologics, anti-aging technology and formulations, therapeutic methods and formulations, organometallic chemistry, food science technologies, and recombinant DNA technologies. She vigorously works to obtain patents for clients and has won on appeal many times at the USPTO.
Doug’s practice is focused on intellectual property contested matters in the areas of patents, trade secrets, and trademarks. His experience includes all aspects of federal IP litigation in numerous district courts across the country and in the Federal Circuit Court of Appeals.
A precise advocate and experienced negotiator, Doug’s expertise spans every phase of the dispute resolution process, from pre-suit investigation through appeal. Doug also devotes a substantial portion of his practice to Inter Partes Review and other proceedings before the USPTO, where he is admitted as a Patent Attorney. He has also served as litigation counsel in numerous cases under the Hatch-Waxman Act and on behalf of various generic pharmaceutical companies. Doug has also represented clients in International Trade Commission matters, and has experience in arbitration proceedings and other alternative dispute resolution forums, such as the Better Business Bureau’s National Advertising Division.
Dominic is a Director of Varsha Bioscience and Technology India Pvt Ltd taking care of its international operations. He will be presenting this paper on behalf of the authors Dr. A. John Peter, Dr. E. Leo Daniel Amalraj, and Dr. Venkateswara Rao Talluri who are part of the technical/research team of the company.
Kelly Rahn specializes in the registration and ongoing compliance of pesticides at the US state and federal level, with an emphasis on antimicrobials and conventional chemicals for all major market sectors including agrochemical, consumer, structural pest control, and the industrial/institutional marketplace. She is also well versed in FIFRA's Good Laboratory Practices (GLP) and 6a2 compliance.
Over her 30 year career, Kelly has combined her scientific background in chemistry with her wealth of industry knowledge to address and satisfy data requirements, resolve labeling and efficacy issues, assist companies with negotiating terms in enforcement situations, develop economically beneficial data compensation strategies and manage state product registrations. She has particular expertise in navigating the regulatory challenges associated with registering new active ingredients with EPA and California's Department of Pesticide Regulation (DPR). This experience also leaves her well suited for the defense of older, complex chemistries, especially those undergoing EPA's Registration Review and DPR’s Special Review processes.
Kelly has a BS in Chemistry from the University of Dallas.
Bio Coming Soon
Allie White graduated from Clemson University in 2013 with a BS in Chemical Engineering and has been working for Ingevity ever since. The majority of her career has been as an engineer at Ingevity’s production facility in Charleston, SC. In 2018, she joined the Ingevity agrochemical commercial team where she has been able to apply her technical background.
Michael Ott is the founder and CEO of Rantizo, an agricultural tech company based in Iowa City and the first company legally using drones to spray for agriculture in multiple states.
Before Rantizo, Ott worked in corporate venture capital backed by Monsanto, Novozymes and Bunge and invented a patented technology that delivers tiny amounts of nitrogen on a rice seed as it grows. Ott has a Master’s degree in Chemistry from the University of Iowa and nearly two decades of experience in finance. He is an author on five patent applications and has raised over $150 million in investment over the course of his career.
He resides in Iowa City with his wife Anne, two sons Ryan and Quincy, and daughter Rosalie.
Biography Coming Soon
Jiarui Li, Ph.D., PMP, MBA, President & CEO: Dr. Li is an accomplished scientist and agtech industry leader with over 30 peer-reviewed publications, two patents, and five funded research proposals. His mixture of both scientific and business experience makes him a vital member of the Innatrix team and a key factor in the business development of the company.
